Steven A. Everett
Fundador en MaveriX Oncology, Inc. .
Cargos activos de Steven A. Everett
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | 09/06/2011 | - |
MaveriX Oncology, Inc.
 MaveriX Oncology, Inc. BiotechnologyHealth Technology MaveriX Oncology, Inc. operates as a a biotechnology company. It focuses on the discovery, development, and commercialization of targeted small molecule cancer chemo-immunotherapies. The company was founded by Steven A. Everett and Craig Alan Coburn in 2015 and is headquartered in Palo Alto, CA. | Director/Miembro de la Junta | 01/01/2014 | - |
| Director Ejecutivo | 01/01/2014 | - | |
| Fundador | 01/01/2014 | - |
Historial de carrera de Steven A. Everett
Antiguos cargos conocidos de Steven A. Everett.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University Of Dundee | Corporate Officer/Principal | 01/01/2005 | 01/01/2009 |
Spear Therapeutics Ltd.
 Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom. | Fundador | - | - |
| Corporate Officer/Principal | - | - | |
Cyterix Pharmaceuticals, Inc.
 Cyterix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyterix Pharmaceuticals, Inc. develops cancer therapeutics. It develops cancer therapeutics based on a proprietary OncoCY prodrug discovery approach. The company was founded by Paul R. Ortiz De Montellano, Luis Bayol and Steven A. Everett on April 10, 2010 and is headquartered in San Francisco, CA. | Director/Miembro de la Junta | 09/06/2011 | - |
| Director Ejecutivo | 08/06/2011 | - | |
| Director Técnico/Científico/I+D | 09/06/2011 | - | |
| Fundador | 09/06/2011 | - | |
| Presidente | 08/06/2011 | - |
Formación de Steven A. Everett.
| University of Ulster | Undergraduate Degree |
| Brunel University | Masters Business Admin |
Estadísticas
Internacional
| Reino Unido | 5 |
| Estados Unidos | 4 |
Operativa
| Founder | 3 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
Sectorial
| Consumer Services | 5 |
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Spear Therapeutics Ltd.
Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom. | Health Technology |
Cyterix Pharmaceuticals, Inc.
Cyterix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyterix Pharmaceuticals, Inc. develops cancer therapeutics. It develops cancer therapeutics based on a proprietary OncoCY prodrug discovery approach. The company was founded by Paul R. Ortiz De Montellano, Luis Bayol and Steven A. Everett on April 10, 2010 and is headquartered in San Francisco, CA. | Health Technology |
MaveriX Oncology, Inc.
MaveriX Oncology, Inc. BiotechnologyHealth Technology MaveriX Oncology, Inc. operates as a a biotechnology company. It focuses on the discovery, development, and commercialization of targeted small molecule cancer chemo-immunotherapies. The company was founded by Steven A. Everett and Craig Alan Coburn in 2015 and is headquartered in Palo Alto, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Steven A. Everett
- Experiencia
